KoBioLabs Inc Sustainability Reports
KoBioLabs, Inc. is a biotechnology company focused on developing innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome platform to discover drug candidates for treating immune, metabolic, and brain disorders.
Sector: Manufacturing
Country: South Korea
Exchange: Korea Exchange (KOSDAQ)
FIGI: BBG00XK2WYS0
1 reports from 2023 to 2023
Company Profile
KoBioLabs, Inc. is a biotechnology company focused on developing innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome platform to discover drug candidates for treating immune, metabolic, and brain disorders.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
